GLP-1 agonist

Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
cancer
GLP-1 agonist
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million
Xtalks
Mon, 07/15/24 - 11:27 pm
Amylx
GLP-1 agonist
Eiger BioPharmaceuticals
avexitide
Weight-loss drugs could become a test case for AI
Axios
Tue, 07/9/24 - 09:24 pm
artificial intelligence
weight loss
obesity
GLP-1 agonist
America's doctors need more obesity medicine training
Axios
Tue, 05/28/24 - 10:49 am
physicians
obesity
GLP-1 agonist
Wegovy
GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData
BioSpace
Mon, 05/20/24 - 06:02 pm
GLP-1 agonist
weight loss
obesity
diabetes
As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters
BioSpace
Wed, 05/15/24 - 11:22 am
insulin
GLP-1 agonist
Novo Nordisk
weight loss
Wegovy
Ozempic
diabetes
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Novo Nordisk
Eli Lilly
earnings
obesity
weight loss
GLP-1 agonist
Ozempic
Wegovy
Zepbound
Mounjaro
Key opinion leaders on GLP-1 receptor agonist clinical trial design
Clinical Trials Arena
Fri, 04/26/24 - 11:41 am
clinical trials
GLP-1 agonist
type 2 diabetes
obesity
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Novo Nordisk
Ozempic
Victoza
GLP-1 agonist
thyroid cancer
Parkinson’s disease may be helped by GLP-1 drug, new study finds
Stat
Wed, 04/3/24 - 10:41 pm
GLP-1 agonist
Parkinson's Disease
lixisenatide
Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’
Stat
Thu, 03/21/24 - 06:43 pm
GLP-1 agonist
addiction
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
Medical Marketing and Media
Wed, 03/20/24 - 09:43 pm
GLP-1 agonist
PD-1 inhibitors
Wegovy
Ozempic
Zepbound
Mounjaro
Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s?
Biopharma Reporter
Mon, 03/18/24 - 11:02 am
Eli Lilly
Novo Nordisk
GLP-1 agonist
Zepbound
Wegovy
Amazon
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity
Drugs.com
Sun, 03/10/24 - 08:28 pm
Regor Therapeutics
clinical trials
GLP-1 agonist
RGT-075
obesity
Americans don't think weight-loss drugs will fix the obesity epidemic
Axios
Wed, 02/28/24 - 10:44 am
obesity
weight loss
Ozempic
Wegovy
Zepbound
GLP-1 agonist
GLP1ra’s beyond obesity and diabetes: Is the sky the limit?
Clinical Trials Arena
Mon, 02/26/24 - 11:03 am
GLP-1 agonist
Wegovy
Zepbound
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
obesity
weight loss
GLP-1 agonist
Novo Nordisk
Eli Lilly
Opioid cravings were reduced by anti-obesity drug in small study
Stat
Sun, 02/18/24 - 08:29 pm
GLP-1 agonist
opioids
opioid addiction
clinical trials

Pages